Acrivon Therapeutics (ACRV) Non Operating Income (2021 - 2026)
Acrivon Therapeutics (ACRV) reported Non Operating Income of $704,000 for Q2 2026, down 57.2% from $1.64 million a year earlier and down 18.1% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Non Operating Income (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Acrivon Therapeutics' Non Operating Income came in at $4.15 million, down 50.9% year-over-year; for FY2025, it was $6.21 million, down 28.2% from FY2024.
- By year, Non Operating Income came in at $8.64 million in FY2024 (+28.7%), $6.72 million in FY2023 (+350.7%), $1.49 million in FY2022 and -$59,000 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Non Operating Income since Q3 2022.
- Year over year, Non Operating Income has now declined in each of the last five quarters, with an average decline of 12.2% over the last eight quarters.
- The high point for year-over-year Non Operating Income in five years was Q3 2023 (growth of 343.2%); the low point was Q2 2026 (a decline of 57.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $860,000 (Q1 2026), $1.13 million (Q4 2025) and $1.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Acrivon Therapeutics | 67.27 Mn | -368.26 Mn | - | 704,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 704,000.00 |
| Mar 31, 2026 | 860,000.00 |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.64 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 2.64 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Sep 30, 2023 | 1.67 Mn |
| Jun 30, 2023 | 1.61 Mn |
| Mar 31, 2023 | 1.64 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 377,000.00 |
| Jun 30, 2022 | 105,000.00 |
| Mar 31, 2022 | -8,000.00 |
| Dec 31, 2021 | -73,000.00 |
| Sep 30, 2021 | 231,000.00 |
API Access
Acrivon Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();